Androgen deprivation therapy and acute kidney injury in prostate cancer: room for debate?
- 18 May 2021
- journal article
- editorial
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 24 (4) , 933-934
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hormone therapy use and the risk of acute kidney injury in patients with prostate cancer: a population-based cohort studyProstate Cancer and Prostatic Diseases, 2021
- The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical ProstatectomyUrology Practice, 2021
- Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate ThemEuropean Urology, 2015
- Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate CancerEuropean Urology, 2014
- Androgen Deprivation Therapy and Risk of Acute Kidney Injury in Patients With Prostate CancerJAMA, 2013
- Androgen Deprivation Therapy for Prostate Cancer and Cardiovascular DeathJAMA, 2012
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyThe Lancet Oncology, 2010
- Androgen Deprivation Therapy for Prostate CancerJAMA, 2005
- Early versus deferred androgen suppression in the treatment of advanced prostatic cancerCochrane Database of Systematic Reviews, 2001
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997